ArticleMicrobes and environments2024
A Novel Strain of the Cyanobacterial Growth-promoting Bacterium, Rhodococcus sp. AF2108, Enhances the Growth of Synechococcus elongatus.
Article in Microbes and environments, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To enhance the growth of the cyanobacterium Synechococcus elongatus, the present study conducted direct screening for cyanobacterium growth-promoting bacteria (CGPB) using co-cultures. Of the 144 strains obtained, four novel CGPB strains were isolated and phylogenetically identified: Rhodococcus sp. AF2108, Ancylobacter sp. GA1226, Xanthobacter sp. AF2111, and Shewanella sp. OR151. A co-culture of S. elongatus with the most effective CGPB strain, Rhodococcus sp. AF2108, achieved a 8.5-fold increase in the chlo-rophyll content of cyanobacterial cells over that in a monoculture. A flow cytometric ana-lysis showed a 3.9-fold increase in the number of S. elongatus cells in the co-culture with Rhodococcus sp. AF2108. These results were attributed to increases in forward scattering and chlo-rophyll fluorescence intensities. The new Rhodococcus strain appears to be one of the most effective CGPBs described to date.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.